Company Filing History:
Years Active: 2014-2018
Title: Simone Sell - Innovator in Nucleic Acid Technologies
Introduction
Simone Sell is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of nucleic acid technologies, holding two patents that showcase her innovative approach to molecular binding.
Latest Patents
Her latest patents include a nucleic acid molecule having binding affinity to a target molecule and a method for generating the same. This invention outlines a method for creating a nucleic acid molecule capable of binding to a target molecule through a series of systematic modifications. The process involves providing a reference nucleic acid molecule, preparing first-level derivatives by altering nucleotide positions, and generating a group of derivatives that differ by single nucleotide replacements. Another notable patent is related to hepcidin binding nucleic acids, which focuses on a nucleic acid capable of binding to hepcidin, a key regulator in iron metabolism.
Career Highlights
Throughout her career, Simone has worked with notable companies such as Noxxon Pharma AG and Aptarion Biotech AG. Her experience in these organizations has allowed her to develop her expertise in biotechnology and molecular research.
Collaborations
Simone has collaborated with esteemed colleagues, including Sven Klussmann and Christian Maasch, contributing to advancements in her field.
Conclusion
Simone Sell's innovative work in nucleic acid technologies highlights her role as a leading inventor in the biotechnology sector. Her patents reflect her commitment to advancing scientific knowledge and practical applications in molecular binding.